KENNEDY CAPITAL MANAGEMENT LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 884589
ST LOUIS, MO
Position in HALO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$31,318,405
+$2,125,954 QoQ
Shares Held
484,580
+11.7% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84.7500928639234.ToString("F0")%
Shared 0.ToString("F0")%
None 15.249907136076601.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $354,986,312 across 62 Biotechnology names. HALO ranks #1 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
484,580 | $31,318,405 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
1,199,598 | $29,702,046 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
137,099 | $14,450,234 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
360,490 | $13,875,260 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
408,492 | $13,075,828 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
304,615 | $12,279,030 | |
| 7 | CLDX |
Celldex Therapeutics, Inc.
|
352,302 | $11,175,019 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
122,669 | $10,325,049 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,318,405 | 484,580 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $29,192,451 | 433,766 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,130,070 | 383,557 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,602,657 | 415,276 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $30,274,845 | 474,453 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $18,838,383 | 394,026 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,866,384 | 364,542 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,127,150 | 441,695 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,872,745 | 513,096 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,497,679 | 662,816 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $24,695,345 | 646,475 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $22,276,651 | 617,595 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,236,646 | 503,709 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $32,671,638 | 574,194 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,533,864 | 645,773 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,488,484 | 602,011 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $22,414,554 | 562,050 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,703,025 | 539,742 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $22,316,356 | 548,583 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $16,033,317 | 353,079 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,819,836 | 355,477 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $14,199,195 | 332,456 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,785,535 | 334,305 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,023,146 | 336,559 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,180,302 | 343,541 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||